cell cycle checkpoint/DNA repair antagonist IC83
Term · Oncology and biomedicine · MLC-T-ONC-012505
A proprietary agent with potential antineoplastic activity. IC83 appears to target cell cycle checkpoint/DNA repair enzymes, which are involved in the recognition and repair of damaged DNA and are overexpressed in many types of cancer cells. Inhibition of cell cycle checkpoint/DNA repair enzymes may enhance the cytotoxicity of DNA damaging agents and dissipate tumor cell resistance to chemotherapy and radiation therapy.
| Identifier | MLC-T-ONC-012505 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012505",
"term": "cell cycle checkpoint/DNA repair antagonist IC83",
"field": "Oncology and biomedicine",
"definition": "A proprietary agent with potential antineoplastic activity. IC83 appears to target cell cycle checkpoint/DNA repair enzymes, which are involved in the recognition and repair of damaged DNA and are overexpressed in many types of cancer cells. Inhibition of cell cycle checkpoint/DNA repair enzymes may enhance the cytotoxicity of DNA damaging agents and dissipate tumor cell resistance to chemotherapy and radiation therapy.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/cell-cycle-checkpoint-dna-repair-antagonist-ic83/"
}
Record 4,551 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.